Top 50 Life Science Startup Investors in United Kingdom (September 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Parkwalk Advisors
VC Fund
|
24 | United Kingdom, United States, Philippines | Seed, Series A, Series B | Biotechnology, Health Care, Software | $991k–$45M |
|
UK Innovation & Science Seed Fund
VC Fund
|
16 | United Kingdom, United States | Seed, Series A | Biotechnology, Health Care, Medical | $482k–$14M |
|
Oxford Science Enterprises
VC Fund
|
16 | United Kingdom, United States, Finland | Seed, Series A, Series B | Health Care, Biotechnology, Software | $1.3M–$168M |
|
SOSV
VC Fund
|
13 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
Future Planet Capital
VC Fund
|
13 | United Kingdom, United States, Singapore | Seed, Convertible Note | Biotechnology, Health Care, Software | $670k–$5.1M |
|
Syncona Partners LLP
VC Fund
|
12 | United Kingdom, United States, Switzerland | Series A, Series B, Seed | Biotechnology, Medical, Health Care | $1.9M–$156M |
|
Development Bank of Wales
VC Fund
|
11 | United Kingdom, Australia, United States | Seed, Debt Financing, Venture - Series Unknown | Software, Health Care, Manufacturing | $19k–$5.4M |
|
24 Haymarket
VC Fund
|
11 | United Kingdom, United States | Venture - Series Unknown, Seed, Series A | Health Care, Software, Biotechnology | $107k–$16M |
|
IQ Capital
VC Fund
|
11 | United Kingdom, United States, Germany | Seed, Series A | Software, Artificial Intelligence, Machine Learning | $1.3M–$40M |
|
Jonathan Milner
Angel
|
11 | United Kingdom, United States, Spain | Seed, Series A, Series B | Biotechnology, Health Care, Medical | $537k–$56M |
|
Selvedge Venture
VC Fund
|
9 | United Kingdom, United States, Canada | Seed, Series A, Pre-Seed | Biotechnology, Health Care, Medical | $1.1M–$30M |
|
Sofinnova Partners
VC Fund
|
9 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $7M–$105M |
|
Techstart Ventures
VC Fund
|
8 | United Kingdom, Ireland, United States | Seed, Pre-Seed | Software, Information Technology, Health Care | $197k–$4M |
|
Angels in MedCity
VC Fund
|
8 | United Kingdom, United States | Seed, Angel | Health Care, Biotechnology, Medical | $313k–$2M |
|
GM&C Life Sciences Fund
VC Fund
|
8 | United Kingdom, Italy, Germany | Seed, Series A | Health Care, Biotechnology, Medical | $94k–$4.2M |
|
Scottish Enterprise
VC Fund
|
8 | United Kingdom, United States, Switzerland | Grant, Seed, Venture - Series Unknown | Biotechnology, Software, Health Care | $119k–$9.4M |
|
Newable Private Investing
VC Fund
|
8 | United Kingdom, United States | Seed, Series A | Software, Health Care, Biotechnology | $196k–$5.6M |
|
Maven Capital Partners
VC Fund
|
8 | United Kingdom, United States, Germany | Venture - Series Unknown, Seed, Private Equity | Software, Information Technology, SaaS | $648k–$15M |
|
O2h Ventures
VC Fund
|
8 | United Kingdom, Hungary | Seed, Venture - Series Unknown, Series A | Biotechnology, Health Care, Pharmaceutical | $603k–$25M |
|
Calculus Capital
VC Fund
|
7 | United Kingdom, United States, Ireland | Venture - Series Unknown, Series A | Biotechnology, Software, Medical | $1.9M–$10M |
|
Google Ventures
VC Fund
|
7 | United States, United Kingdom, Israel | Series A, Series B, Seed | Software, Health Care, Biotechnology | $1.2M–$121M |
|
Archangels
VC Fund
|
7 | United Kingdom, United States | Venture - Series Unknown, Seed | Software, Health Care, Biotechnology | $867k–$6.3M |
|
SR One
VC Fund
|
6 | United States, United Kingdom, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $6M–$175M |
|
Scottish Investment Bank
VC Fund
|
6 | United Kingdom, United States, France | Venture - Series Unknown, Seed, Series A | Software, Biotechnology, Health Care | $245k–$7.9M |
|
Kindred Capital
VC Fund
|
6 | United Kingdom, United States, Germany | Seed, Series A, Series B | Software, Biotechnology, Health Care | $1.4M–$73M |
|
Northstar Ventures
VC Fund
|
5 | United Kingdom, United States, Indonesia | Seed, Venture - Series Unknown, Series A | Software, Health Care, E-Commerce | $39k–$10M |
|
Antler
VC Fund
|
5 | Singapore, Australia, United Kingdom | Pre-Seed, Seed, Series A | Software, Artificial Intelligence, Information Technology | $100k–$29M |
|
Deepbridge Capital
VC Fund
|
5 | United Kingdom, Spain, Australia | Seed, Venture - Series Unknown, Series A | Health Care, Biotechnology, Medical | $142k–$15M |
|
Epidarex Capital
VC Fund
|
5 | United Kingdom, United States, Germany | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $531k–$48M |
|
APEX Ventures
VC Fund
|
5 | Germany, United Kingdom, Austria | Seed, Series A, Pre-Seed | Artificial Intelligence, Software, Health Care | $552k–$22M |
|
Cambridge Innovation Capital
VC Fund
|
5 | United Kingdom, United States, Ireland | Series A, Series B, Seed | Biotechnology, Health Care, Medical | $2.5M–$73M |
|
Lima Ventures
VC Fund
|
5 | Turkey, Estonia, United Kingdom | Seed, Pre-Seed | Artificial Intelligence, Software, FinTech | $20k–$697k |
|
Nadav Rosenberg
Angel
|
5 | United Kingdom, France, Israel | Seed, Pre-Seed, Series A | Software, Biotechnology, Artificial Intelligence | $1.1M–$21M |
|
IP Group
VC Fund
|
5 | United Kingdom, United States, Australia | Seed, Series A | Health Care, Biotechnology, Therapeutics | $438k–$30M |
|
Verve Ventures
VC Fund
|
5 | Switzerland, Germany, France | Series A, Seed, Series B | Health Care, Software, Biotechnology | $1.4M–$45M |
|
Amadeus Capital Partners
VC Fund
|
5 | United Kingdom, United States, Spain | Series A, Seed, Series B | Software, Artificial Intelligence, Information Technology | $800k–$56M |
|
Formic Ventures
VC Fund
|
5 | United States, United Kingdom, Hong Kong | Seed, Series A, Venture - Series Unknown | Biotechnology, Health Care, Pharmaceutical | $958k–$61M |
|
Advent Life Sciences
VC Fund
|
4 | United States, United Kingdom, France | Series A, Series B | Biotechnology, Health Care, Medical | $5.5M–$105M |
|
SFC Capital
VC Fund
|
4 | United Kingdom, United States, Canada | Pre-Seed, Seed | Artificial Intelligence, Software, Information Technology | $127k–$2M |
|
Episode 1
VC Fund
|
4 | United Kingdom, United States, Germany | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, SaaS | $1M–$18M |
|
Molten Ventures
VC Fund
|
4 | United Kingdom, United States, Germany | Series A, Series B, Series C | Software, Information Technology, FinTech | $3.2M–$200M |
|
Mercia Fund Managers
VC Fund
|
4 | United Kingdom, United States, Hungary | Seed, Venture - Series Unknown | Software, Health Care, Biotechnology | $250k–$5.3M |
|
Acequia Capital (AceCap)
VC Fund
|
4 | United States, United Kingdom, France | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, Information Technology | $500k–$25M |
|
Ahren Innovation Capital
VC Fund
|
4 | United Kingdom, United States, Israel | Series A, Seed, Series B | Biotechnology, Artificial Intelligence, Machine Learning | $2.7M–$150M |
|
AlbionVC
VC Fund
|
4 | United Kingdom, United States, France | Series A, Seed | Software, Information Technology, Health Care | $2.4M–$19M |
|
Martlet Capital
VC Fund
|
4 | United Kingdom, United States | Seed, Series A, Pre-Seed | Health Care, Biotechnology, Software | $193k–$9.5M |
|
Playfair Capital
VC Fund
|
4 | United Kingdom, United States, Switzerland | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Machine Learning | $953k–$19M |
|
Catapult Ventures
VC Fund
|
4 | United Kingdom, United States, Israel | Seed, Venture - Series Unknown | Health Care, Biotechnology, Medical | $150k–$5.6M |
|
Fifty Years
VC Fund
|
4 | United States, Germany, Canada | Seed, Series A, Series B | Biotechnology, Health Care, Artificial Intelligence | $2M–$91M |
|
Beltrae Partners
VC Fund
|
4 | United Kingdom | Seed, Series A | Health Care, Life Science, Biotechnology | |
| Access all 802 investors in United Kingdom Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009,anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth.Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Philippines
Investor stats
- Total investments: 316
- Round size: Seed $991k–$4.9M; Series A $1.6M–$14M; Series B $2.2M–$45M
- Lead/follow: 28% lead, 72% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- xWatts — xWatts is an intelligent energy management software that reduces energy costs and emissions in commercial buildings.
- K3 Metrology — K3 Metrology is a specialist metrology company commercialising laser‑based 3D coordinate measurement technology developed at the National Physical Laboratory. The company’s platform is designed to provide high‑accuracy, uncertainty‑aware dimensional data in large‑volume industrial environments, supporting inspection and assembly processes inadvanced manufacturing. Its systems integrate into production workflows where traceable measurements are required across complex geometries and large structures. The technology is applied in sectors such as aerospace, defence, and nuclear, where dimensional integrity and process control are critical.
- MoA Technology — We harness the principles of natural selection to accelerate discovery for better, safer herbicides so farmers can continue to feed the world.
UKI2S, formally the Rainbow Seed Fund, is an investment fund backed by the government, providing seed funding to science & technology start-ups and SMEs
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 147
- Round size: Seed $482k–$5.9M; Series A $2.9M–$14M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — last raise in 2014
Portfolio highlights
- Zentraxa — NATURE ENGINEERED FOR PURPOSE Through millions of years of evolution, nature has found solutions to the most difficult problems. Inspired by the diversity of nature, we precision engineer bespoke biomaterials to meet the toughest challenges across
- Singular Machines — Singular Machines is an engineering automation company that provides solutions to engineering issues.
- Halo X Ray Technologies — HALO X-ray Technologies - next generation X-ray diffraction technology for the aviation security, medical and process control markets.
Oxford Science Enterprises is the university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companies taking onchallenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Finland
Investor stats
- Total investments: 202
- Round size: Seed $1.3M–$12M; Series A $6.3M–$45M; Series B $9.1M–$168M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $299M in 2022
Portfolio highlights
- Caudal Energy — Porpoise Power develops a tidal energy system using oscillating hydrofoil technology inspired by dolphin swimming mechanics.
- Singular Machines — Singular Machines is an engineering automation company that provides solutions to engineering issues.
- Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Brilliant Ideas. Brilliant People. Brilliant Minds.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note
- Geography: United Kingdom, United States, Singapore
Investor stats
- Total investments: 264
- Round size: Seed $670k–$5.1M
- Lead/follow: 5% lead, 95% follow
- Last fund: Likely still investing — raised $23M in 2022
Portfolio highlights
- Unloq AI — Unloq is a Decision Intelligence Platform that turns your company data and live market signals into governed strategic recommendations. Approved, tracked, measured.
- Nourished — At Nourished we create innovative. personalised nutrition stacks that are truly unique to you. Vegan, waste-free and always made to order.
- K3 Metrology — K3 Metrology is a specialist metrology company commercialising laser‑based 3D coordinate measurement technology developed at the National Physical Laboratory. The company’s platform is designed to provide high‑accuracy, uncertainty‑aware dimensional data in large‑volume industrial environments, supporting inspection and assembly processes inadvanced manufacturing. Its systems integrate into production workflows where traceable measurements are required across complex geometries and large structures. The technology is applied in sectors such as aerospace, defence, and nuclear, where dimensional integrity and process control are critical.
Syncona is a FTSE250 company focused on founding, building and funding healthcare companies to deliver transformational treatments to patients in areas of high unmet need.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Series A, Series B, Seed
- Geography: United Kingdom, United States, Switzerland
Investor stats
- Total investments: 75
- Round size: Seed $1.9M–$17M; Series A $13M–$87M; Series B $29M–$156M
- Lead/follow: 59% lead, 41% follow
Portfolio highlights
- Apini Therapeutics — Apini is a creating novel small chemical two most prevalent types of inflammatory bowel disease.
- Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
- Re-Aim Therapeutics — Re‑Aim Therapeutics is a UK‑based biotech start‑up developing functional cures for T cell–mediated autoimmune diseases by selectively depleting pathogenic T‑cell subsets. Its lead asset, REA‑001, is a monoclonal antibody designed to potently and precisely eliminate disease‑causing type‑17 T cells, aiming to reset the immune system and achievedurable, treatment‑free remission in multiple autoimmune conditions.
Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.
Show more...Investment focus
- Industry: Software, Health Care, Manufacturing
- Stage:Seed, Debt Financing, Venture - Series Unknown
- Geography: United Kingdom, Australia, United States
Investor stats
- Total investments: 284
- Round size: Seed $365k–$3M; Debt Financing $19k–$3.7M; Venture - Series Unknown $383k–$5.4M
- Lead/follow: 63% lead, 37% follow
- Last fund: May invest from a new fund soon — raised $27M in 2018
Portfolio highlights
- Reacta Biotech — Reacta Biotech has been established to develop, manufacture and commercialise oral food challenge materials to pharmaceutical standards of Good Manufacturing Practice (GMP).
- Design and Supply — Design and Supply are specialist manufacturers and suppliers of Industrial Steel Doors and Architectural Products.
- MeOmics Technology — MeOmics Technology is a biotech company with a focus on improving the diagnosis and treatment of mental health illnesses. The company operates in the manufacturing industry and has a team of 9 employees. The team includes experts in Neuronal Cell Biology and Neuropsychopharmacology. The company's mission is to leverage technology to enhancethe understanding and treatment of mental health conditions.
24Haymarket is an investment network which included several highly-experienced private equity and venture capital investors, seasoned entrepreneurs, and senior operators. Investing up to £5 million in growth companies in the UK and Europe. They invested their own capital in direct alignment with entrepreneurs and actively support their growthagenda and join the board of the companies in which they invest. Since inception in 2011, 24Haymarket has invested in more than 50 high-growth businesses.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Venture - Series Unknown, Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 108
- Round size: Seed $736k–$3.7M; Series A $1.6M–$16M; Venture - Series Unknown $107k–$4.6M
- Lead/follow: 41% lead, 59% follow
Portfolio highlights
- WATR — WATR is the integrated system for real-time water or soil quality monitoring. Our products are robust, reliable, accurate, easy to use and benchmarked for accuracy.
- pixlbio (formerly DefiniGEN) — Generate metabolic disease phenotypes in primary-like human cells using the best-in-class human iPSC differentiation platform. Find out more here!
- Previsico — Discover Previsico's real-time flood forecasting solutions, designed to mitigate risks for businesses and communities worldwide.
IQ Capital is a Cambridge & London-based VC firm that invests in ‘deep tech’ companies capable of dominating their respective markets on a global scale. Initial investments at Seed and Series A range from £0.5m to £10m, with capacity for follow-on investment up to £30m through the Growth Fund. The team has achieved over 30 exits including toApple, Huawei, Google and Oracle.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Machine Learning
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 213
- Round size: Seed $1.3M–$12M; Series A $4.7M–$40M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — raised $200M in 2023
Portfolio highlights
- RevEng — RevEng.AI is a cyber security and artificial intelligence company that helps organizations understand their cyber security supply chain. RevEng.ai identifies fundamental components of closed-source program binaries and generates real-valued vector embeddings for each component.
- Mindgard — Mindgard is the leading provider of AI Red Teaming solutions.
- Imperagen — Imperagen is a biotechnology research company focused on enzyme engineering, artificial intelligence, and synthetic biology.
Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Spain
Investor stats
- Total investments: 63
- Round size: Seed $537k–$25M; Series A $4.5M–$50M; Series B $1.6M–$56M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Quibim — Quibim builds AI tools that turn MRI, CT and PET data into actionable predictions for hospitals and biopharma. Trusted in 230+ centers worldwide.
- Nuclera — Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers. Nuclera's eProtein DiscoveryTM system allows scientists to rapidly produce and test proteins for drug discovery.
- 52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Selvedge Venture operates as a venture capital firm investing for impact in age-related medical conditions.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, United States, Canada
Investor stats
- Total investments: 20
- Round size: Seed $1.4M–$9.6M; Pre-Seed $1.1M–$2.5M; Series A $3.5M–$30M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- Mesh Bio — We enable digital transformation of care delivery through clinical workflow automation and predictive analytics, built on gold standard clinical guidelines and best practices.
- BIOS — BIOS Health is unlocking the potential of the nervous system in treating chronic disease by using AI-powered neural interfaces that can automatically read and write neural signals.
- MultiOmic Health — AI-Enabled Precision Medicine for Metabolic Syndrome
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 348
- Round size: Series A $7M–$70M; Series B $10M–$105M; Series C $12M–$100M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely actively investing — fresh fund, raised $755M in 2025
Portfolio highlights
- Odoo — From ERP to CRM, eCommerce and CMS. Download Odoo or use it in the cloud. Grow Your Business.
- Mironid — Google Analytics is a web analysis service provided by Google. Google utilizes the data collected to track and examine the use of www.mironid.com, to prepare reports on its activities and share them with other Google services. Google may use the data collected to contextualize and personalize the ads of its own advertising network.
- Forth Therapeutics — Forth Therapeutics is a biotechnology company dedicated to advancing precision treatments for fibrosis.
Techstart Ventures is a first-cheque investor for extraordinary founders pursuing uncapped global opportunities.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Pre-Seed
- Geography: United Kingdom, Ireland, United States
Investor stats
- Total investments: 202
- Round size: Seed $249k–$4M; Pre-Seed $197k–$1.3M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Go Swag — Branded gifts for people you work with
- Saltroad — Get matched with an experienced HCPC Speech and Language Therapist based on your child's needs, your budget and your schedule. Loved by parents & children.
- Foresight — Foresight turns regulatory change into confident action. Compliance-critical teams see every change that affects their products across chemicals, sustainability, product safety, ESG, and HSE, with the evidence to act.
Angels in MedCity is a partnership between MedCity, London Business Angels and Angels4LifeSciences. The programme aims to introduce new people to investing and investing in the healthcare/life sciences sector via investor workshops and introduce business angels to investment opportunities from highly-selected and trained companies.With aparticular focus on drug therapies, digital health and medical device technologies, Angels in MedCity brings potential investors together with life sciences experts in a programme aimed at both people who are new to investing and experienced investors who have little or no experience in the life sciences sector. The aim is to build investor understanding in the life sciences sector and support life sciences companies to gain funding to commercialise their ideas.Angels in MedCity has created a community of investors supported through a programme of investor workshops. Using case studies and tips from experienced investors in the field, the workshops explain how to identify and structure a good deal in the life sciences sector, as well as provide expert advice on tax breaks and legal issues.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Angel
- Geography: United Kingdom, United States
Investor stats
- Total investments: 20
- Round size: Seed $482k–$2M; Angel $313k–$1.2M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Calira — Calira (formerly Clustermarket). Give researchers an easy way to book equipment, improve equipment utilisation, and get structured lab usage data.
- Atelerix — Discover Atelerix's hypothermic hydrogels for reliable cell preservation and ambient temperature shipping. Ensure fresh, viable cell samples.
- Clustermarket — The intuitive lab management system for all academic research facilities and industrial laboratories that need to efficiently manage equipment bookings.
The GM&C Life Sciences Fund is a seed and early stage venture capital fund targeting life sciences businesses located in the Greater Manchester and Cheshire & Warrington region. The Fund is managed by Catapult Venture Managers ("Catapult Ventures").The Fund is based at Alderley Park, which is well recognised as a site ofnational importance, being the largest life sciences campus of its kind in the UK with more than 500,000 sq. ft. of top-end laboratory and related space and facilities. Until recently, the Park was the R&D headquarters for AstraZeneca.Since 2002, Catapult Ventures has backed a significant number of companies across a broad range of life sciences, including therapeutics (such as Abzena and Oxford BioTherapeutics), medical devices (such as Monica Healthcare and Probe Scientific), contract research organisations (such as R5 Pharmaceuticals and FDAS), diagnostics developers (such as Lumora and Biofortuna), as well as developers of technology used in healthcare applications (such as Oxford Cryosystems and Accutronics). The Fund is the result of a collaboration between Cheshire and Warrington Enterprise Partnership, Greater Manchester Combined Authority, Cheshire East Council, and Manchester Science Partnerships.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: United Kingdom, Italy, Germany
Investor stats
- Total investments: 36
- Round size: Seed $94k–$1.9M; Series A $1.9M–$4.2M
- Lead/follow: 64% lead, 36% follow
Portfolio highlights
- ScubaTx — ScubaTx is a breakthrough organ preservation device organ transplant. The ScubaTx device will leverage world-leading expertise in software design to commercialise a proven but unexploited organ preservation technique, Persufflation. ScubaTx will offer healthcare providers significant net savings, an
- Infex Therapeutics — Infex Therapeutics acquires, develops and licenses innovative drugs to treat pandemic infections
- Monument Therapeutics — Monument Therapeutics is a biotechnology company intended to develop drugs to treat serious diseases of the central nervous system.
Scotland's business advice, support and funding agency. Explore our products and services to find the right support for your business and apply online today.
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Grant, Seed, Venture - Series Unknown
- Geography: United Kingdom, United States, Switzerland
Investor stats
- Total investments: 389
- Round size: Seed $387k–$4.3M; Grant $119k–$4.2M; Venture - Series Unknown $928k–$9.4M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- Kenoteq — Discover Kenoteq, pioneering the sustainable construction revolution with our innovative, ultra low-carbon building materials.
- QuickBlock — QUICKBLOCK delivers training environments, deployable infrastructure and force protection solutions for defence and security organisations worldwide.
- Singular Photonics — Singular Photonics is a startup that creates SPAD-based image sensors.
Newable: Helping over 20,000 businesses thrive annually with tailored financial products, advice, and flexible workspace solution
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 106
- Round size: Seed $196k–$3.1M; Series A $1.3M–$5.6M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Delta g — Delta g Limited is a quantum technology and gravity gradiometry company. A spin-out from the University of Birmingham our technology has applications in industries as varied as civil engineering, infrastructure, defence, rail, navigation and resource exploration. Experts from science, engineering an
- Weldfast — Weldfast is a manufacturer and supplier of welding consumables, abrasives, chemicals, premium gas equipment, and safety products.
- EarSwitch — Empowering new ways to control and connect with the world through in-ear biometric switch and sensor technology
Maven is one of the UK's leading private equity and investment firms. We provide essential capital and expertise to help businesses unlock their potential.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Venture - Series Unknown, Seed, Private Equity
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 212
- Round size: Seed $792k–$5M; Private Equity $981k–$15M; Venture - Series Unknown $648k–$8.1M
- Lead/follow: 75% lead, 25% follow
- Last fund: May invest from a new fund soon — raised $132M in 2019
Portfolio highlights
- KubeNet — We are KubeNet - a multi-award winning technology solutions provider based in Glasgow. Whether it's Managed IT, IT Support, Cloud, Connectivity, Voice or Cyber Security, we're by your side as your trusted technology partner.
- Tixserve — Secure, Trackable, Interactive Digital Tickets for Live Events
- ReadyGo Diagnostics — ReadyGo Diagnostics has invented a novel “Diagnostic Pen”. Low cost, intuitive to use from the raw sample, the ReadyGo Pen will be a game-changer in the newly emerging consumer diagnostics market, offering a yes/no answer in minutes, based on molecular analysis.
Transforming UK biotech breakthroughs into impact. o2h Ventures offers SEIS/EIS and growth-stage funds to back visionary teams from seed to clinical success.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: United Kingdom, Hungary
Investor stats
- Total investments: 60
- Round size: Seed $603k–$7.3M; Series A $1.9M–$25M; Venture - Series Unknown $1.1M–$2.9M
- Lead/follow: 47% lead, 53% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Healx — At Healx we use AI drug discovery to develop new treatments for rare diseases. We bring treatments from prediction to patient.
- Atelerix — Discover Atelerix's hypothermic hydrogels for reliable cell preservation and ambient temperature shipping. Ensure fresh, viable cell samples.
- Monument Therapeutics — Monument Therapeutics is a biotechnology company intended to develop drugs to treat serious diseases of the central nervous system.
At Calculus Capital they are specialists in creating and managing tax efficient private equity funds for the individual. Funds that are ideal for today's market - offering generous tax benefits, and significant growth potential within a sensible risk profile.They look to make £2-5 million investments in established companies with provenmanagement teams and a successful product or service. Their entrepreneurial flair, combined with their experience and sound commercial judgement has resulted in a diversified investment portfolio and an impressive track record. In June 2013 Calculus Capital was top ranked in the prestigious Martin Churchill Tax Efficient Review for the 6th year in a row. The Government has recently shown its support for EIS funds, by maintaining the five generous tax benefits and widening the scope of EIS investments. These changes benefit Calculus Capital's rigorous and proven strategy. As a result they are experiencing their strongest pipeline of prospective investments yet.
Show more...Investment focus
- Industry: Biotechnology, Software, Medical
- Stage:Venture - Series Unknown, Series A
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 80
- Round size: Series A $2.5M–$10M; Venture - Series Unknown $1.9M–$7.8M
- Lead/follow: 65% lead, 35% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- Edify Systems — The Human-First AI platform for multi-site food and beverage operators. Tighter margins, less waste, more time on the floor.
- Grateful — Grateful provides cashless tipping and trunk management software that integrates QR/NFC, EPOS systems, and compliance reporting.
- Resurrect Bio — Resurrect Bio is a disease resistance trait discovery company. Using AI and our high-throughput in planta screening platform we provide traits for breeders.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!GV supports innovative founders moving the world forward.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 1425
- Round size: Seed $1.2M–$16M; Series A $6M–$100M; Series B $16M–$121M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — raised $100M in 2014
Portfolio highlights
- Gusto — Gusto develops web-based payroll solution for small- and medium-sized businesses. It operates an online platform that provides payroll, benefits, human resources, and integration services for employers and employees in the United States.Gusto offers health benefits and workers’ compensation benefits that include medical insurance, commuterbenefits, and 401(k) contributions as well as workers’ compensation insurance plans, time tracking, and integration services, and access to employees for processing payroll from web-enabled devices such as smartphones and tablets. It also provides access to employees and contractors to browse their previous pay stubs, review their payroll forms, verify their personal details, and statistics about their pay, tax payments and federal forms filing services, and security and support services.Gusto serves startups, coffee shops, doctors, creative agencies, lawyers, and boutiques. Edward Kim, Joshua Reeves, and Tomer London founded ZenPayRoll in 2011 that became Gusto, with its headquarters in San Francisco in California with an additional office in Denver in Colorado.
- Wonder — Introducing a new kind of home dining experience. Currently available in areas of New Jersey.
- OpenEvidence — OpenEvidence uses artificial intelligence to aggregate, synthesize, and visualize clinical evidence in understandable, clinically-useful formats that can be used to make more evidenced-based decisions and improve patient outcomes.
Established in 1992. Archangels is the oldest continuously operating business angel syndicate in the World. Investing in IP-rich tech & life sciences companies in Scotland, UK.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Venture - Series Unknown, Seed
- Geography: United Kingdom, United States
Investor stats
- Total investments: 85
- Round size: Seed $1.3M–$4.1M; Venture - Series Unknown $867k–$6.3M
- Lead/follow: 54% lead, 46% follow
Portfolio highlights
- BioCaptiva — BioCaptiva develops liquid biopsy technology devices to diagnose and monitoring to detect cancers.
- Bioliberty — Engineering the future of physical and occupational therapy.
- Earth Blox — Earth Blox provides a platform for analyzing geospatial data through a visual interface for environmental and land analysis. The system enables users to build workflows using satellite imagery and other earth observation datasets without requiring extensive coding knowledge. It supports applications such as deforestation tracking, carbonmonitoring, agriculture assessment, and land use analysis.The platform integrates data sources and processing tools to help users generate insights, automate analyses, and export results for reporting or further use. It also allows collaboration across teams by sharing workflows and outputs within a unified environment. Earth Blox supports organizations working with geospatial intelligence by simplifying access to large-scale environmental data and analysis tools.
SR One Capital Management is a leading trans-Atlantic biotech venture capital firm that partners with top entrepreneurs, scientists and investment partners to seek to build elite biotechnology companies. Our mission is to translate ground-breaking technologies into next generation medicines to benef
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 200
- Round size: Series A $6M–$100M; Series B $15M–$114M; Series C $22M–$175M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely actively investing — fresh fund, raised $237M in 2025
Portfolio highlights
- CalciMedica — CalciMedica was founded in December 2006 by Gonul Velicelebi, Ph.D., Kenneth Stauderman, Ph.D. and Jack Roos, Ph.D., all previously with TorreyPines Therapeutics, where they discovered the role of STIM1 in the Icrac pathway in 2003. Other co-founders, all from the CBR Institute, include Anjana Rao, Ph.D., Patrick Hogan, Ph.D. and Stefan Feske, M.D,who identified Orai1 as the CRAC channel subunit in 2006.
- Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological diseases.
- CHARM Therapeutics — CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins.
Speak with our team, who can help you find sources of finance, engage with funders and secure investment to grow your business.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Venture - Series Unknown, Seed, Series A
- Geography: United Kingdom, United States, France
Investor stats
- Total investments: 270
- Round size: Seed $331k–$3.1M; Series A $1.7M–$7.9M; Venture - Series Unknown $245k–$4.4M
- Lead/follow: 13% lead, 87% follow
- Last fund: May invest from a new fund soon — last raise in 2015
Portfolio highlights
- Bio-Images Drug Delivery — BDD Pharma combine drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and new innovative pharmaceutical products. Rapid parallel clinical testing with SWIFT significantly reduces time from product concept to clinical success.
- IOTech — Discover IOTech Systems. Deploy, manage, and scale AI-driven, data-rich industrial systems at the edge with our open edge data platform.
- Administrate — Manage instructor-led training with Administrate. Plan, schedule, communicate, resolve issues, and report on training operations from one platform.
A new model for Venture Capital where every founder we back becomes a co-owner of the fund.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 128
- Round size: Seed $1.4M–$16M; Series A $7.9M–$33M; Series B $8M–$73M
- Lead/follow: 30% lead, 70% follow
- Last fund: Likely actively investing — fresh fund, raised $8M in 2026
Portfolio highlights
- ZML — ZML is a production inference stack, purpose-built to decouple AI workloads from proprietary hardware.
- Bios Life — Bios Life is a technology-enabled healthcare company built to empower individuals to proactively manage their cancer risk, redefining personalized cancer screening and survivorship.
- Fractile — Fractile is designing AI compute systems that will enable the next generation of AI scaling: frontier model inference, 25x faster, at 1/10th the cost.
Northstar Ventures invests venture capital in early and later stage, high growth companies tackling global challenges, focusing on climate tech and healthy ageing.
Show more...Investment focus
- Industry: Software, Health Care, E-Commerce
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: United Kingdom, United States, Indonesia
Investor stats
- Total investments: 215
- Round size: Seed $39k–$2.1M; Series A $295k–$10M; Venture - Series Unknown $208k–$8.8M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely still investing — raised $20M in 2024
Portfolio highlights
- H2CHP — H2CHP's Free Piston Engine Technology enables your transition to green energy with the reliability & confidence of fuel flexibility.
- NunaBio — NunaBio operates as a privately-owned specialist DNA development company. NunaBio engaged in CRO (Contract Research Organizations) and CDMO (Contract Development and Manufacturing Organisation) activities.
- Advanced Electric Machines — Our magnet free motors help manufacturers build more sustainable vehicles and products. See how we can help you today.
Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: Singapore, Australia, United Kingdom
Investor stats
- Total investments: 2372
- Round size: Seed $158k–$4.5M; Pre-Seed $100k–$587k; Series A $4.1M–$29M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely actively investing — fresh fund, raised $7.5M in 2026
Portfolio highlights
- Two — Buy Now, Pay Later for your business customers. Two makes it easy and safe to offer invoice as a payment method on your e-commerce site.
- Forti Foods — The mission of Forti Foods is to enhance communities and change lives beyond the plate by fostering resilience and dignity via sustainable food innovation.
- RubiLabs — RubiLabs Inc provides a platform for unifying, monitoring, and analyzing organizational data. RubiLabs software enables analysts and operators across risk, compliance, and security teams to collaborate and interpret large volumes of information in real time. The company’s platform is designed to help institutions make sense of complex, fragmenteddata by transforming it into a coherent operational picture for risk detection, continuous monitoring, and investigative workflows.
Deepbridge is a different kind of investment manager. They work closely with financial advisers and investors to design innovative products, ranging from investment in technology growth companies to asset-backed renewable energy projects. They also partner with innovative and committed management teams to help UK based companies realise theirpotential and become successful leading-edge businesses.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: United Kingdom, Spain, Australia
Investor stats
- Total investments: 91
- Round size: Seed $142k–$2.4M; Series A $2M–$15M; Venture - Series Unknown $259k–$2.8M
- Lead/follow: 69% lead, 31% follow
- Last fund: Likely still investing — raised $1.4M in 2022
Portfolio highlights
- upLYFT — upLYFT creates next-generation wearable technology that continuously analyses biomechanics and movement biomarkers, giving athletes, clinicians and physiotherapists precise insight into performance, recovery and injury risk.
- GeneralPractice.AI — GeneralPractice.AI - Infusing Artificial Intelligence into the Fabric of General Practice
- Spotlight Pathology — Spotlight Pathology develops decision support tools powered by artificial intelligence (AI) to help in the diagnosis of blood cancers.
Epidarex Capital invests in early-stage, high growth life science and health technology companies in under-ventured markets. Its international team is led by Sinclair Dunlop, Kyp Sirinakis and Liz Roper. With offices in the United States and United Kingdom Epidarex Capital’s investors represent a cross-section of leading universities, internationalcorporations, development agencies and financial institutions. Epidarex was created to meet the need for more sector-specific financial backing for young companies, including spin-outs from leading research universities.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 51
- Round size: Seed $531k–$8.5M; Series A $2.6M–$38M; Series B $2.4M–$48M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely actively investing — fresh fund, raised $145M in 2026
Portfolio highlights
- Mironid — Google Analytics is a web analysis service provided by Google. Google utilizes the data collected to track and examine the use of www.mironid.com, to prepare reports on its activities and share them with other Google services. Google may use the data collected to contextualize and personalize the ads of its own advertising network.
- RapidPulse — Explore RapidPulse for innovative stroke treatments and technologies. Book appointments or learn about our team and clinical trials.
- Epsilogen — IGEM Therapeutics is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.The company's offerings include IgE-based drugs targeting solid tumors, enabling patients to kill parasites which reside in human tissue, also the home of the solid tumor.
APEX Ventures is a deep-tech and medical focused venture capital firm, run by founders with complimentary backgrounds driven by the same mission.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United Kingdom, Austria
Investor stats
- Total investments: 53
- Round size: Seed $1.4M–$8M; Pre-Seed $552k–$9.1M; Series A $2.4M–$22M
- Lead/follow: 32% lead, 68% follow
Portfolio highlights
- GEMESYS — Gemesys creates a chip that functions similarly to the human brain in order to overcome processing constraints and empower AI with the hardware it needs to complete its destiny
- HyperHeat — HyperHeat is building a cutting-edge, all-electric heating solution designed to reach temperatures of up to 2,000°C. Using renewable electricity HyperHeat is providing an efficient alternative to fossil fuel combustion. With an efficiency rate of up to 98%, HyperHeat is ideal for retrofitting industrial processes, enabling significant CO2reductions across industries like steel, cement, and chemicals. The scalable technology offers a cost-efficient approach to decarbonizing thermal processes, with a potential to reduce global CO2 emissions by over 4.5 gigatons annually.
- TriLite Technologies — The world's smallest projection displays from TriLite take laser beam scanning technology to the next level, for augmented vision as light as the eyewear of today.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!As a team, we have a passion for science and its potential to drive change. Through our expertise and our position in one of the country's most powerful science and technology ecosystems, we're able to identify and support the most promising entrepreneurs in knowledge intensive businesses and help them achieve their vision.With our financial backing and expert guidance, we're excited to enable the pioneers in life sciences and deep tech to create world-leading companies whose unique ideas bring financial success and global impact.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Seed
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 113
- Round size: Seed $2.5M–$31M; Series A $2.6M–$73M; Series B $7.1M–$61M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely actively investing — fresh fund, raised $332M in 2025
Portfolio highlights
- Immutrin — Immutrin is a biotechnology company developing next‑generation antibody therapies designed to clear systemic amyloid deposits and reverse amyloidosis, this company lead asset targets ATTR cardiomyopathy, a severe and progressive form of amyloidosis, and its antibody represents a potential best‑in‑class treatment engineered to selectively andspecifically remove established amyloid fibrils.
- Trent AI — Trent AI creates AI applications and agent security management software. It aids in risk assessment and mitigation in systems utilizing autonomous or semi-autonomous software agents. The company's technology monitors agent activity across APIs, tools, and workflows. It continuously assesses security posture via iterative scanning andcontextual understanding of system architectures.
- TRIMTECH Therapeutics — Transformative treatments for CNS and inflammatory disorders by selectively destroying disease-causing protein aggregates
Collaboration with outstanding initiators with exceptional insights, from inception through all levels of progress. Lima Ventures supports visionary founders as well as provides certain services to early startups. We seek innovative technology-driven entrepreneurs who generate and lead companies that will inspire millions.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, FinTech
- Stage:Seed, Pre-Seed
- Geography: Turkey, Estonia, United Kingdom
Investor stats
- Total investments: 39
- Round size: Seed $20k–$697k; Pre-Seed $50k–$100k
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Shippn — International package forwarding service. Shop from Amazon, Shein, Macy's worldwide. Fast shipping with DHL & FedEx. Trusted by 50,000+ customers.
- heybooster — heybooster is the creator of a platform for marketing analysis that aids e-commerce managers in finding chances for revenue growth and in making better choices. It provides clients with digital reporting, online meetings, online communication, an online project management system, and an online playbook that helps them discover problems, findpossibilities for revenue growth, and cut expenses.
- Mars Studios — Mars Studios is an experienced team of growth hackers & marketers that can help you to increase your revenue. Rocket Your App to Success: Mars Studios
Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.
Show more...Investment focus
- Industry: Software, Biotechnology, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, France, Israel
Investor stats
- Total investments: 16
- Round size: Seed $1.1M–$3.1M; Pre-Seed $2M–$2M; Series A $18M–$21M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- Teora — Crude oil derived products have infiltrated every industry – synthetic colors, flavors, fragrances in food, dyes in textiles, fertilizers and packaging material that harm humans and the planet. TeOra’s mission is to replace synthetics with naturals that are manufactured in a sustainable and predictable manner. A microorganism is the best factory,optimized over billions of years of evolution and TeOra designs it to produce desired products. Using microfluidics and AI, TeOra offers 100 times faster and cheaper design of smart micro-organisms in weeks to months instead of years.
- thymia — We use video games based on Neuropsychology alongside analyses of video and speech to make mental health assessments smart, starting with depression.Our online platform empowers clinicians so they can assess depression faster, more accurately and objectively. Our multi-modal depression recognition and tracking system allows us to find the righttreatment in weeks instead of years and we make the entire process enjoyable for the patient.
- Lindus Therapeutics — Lindus Health. From recruitment to delivery, we accelerate clinical trials. Our mission is to make health research accessible for everyone, everywhere.
IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Therapeutics
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Australia
Investor stats
- Total investments: 211
- Round size: Seed $438k–$8.5M; Series A $2.4M–$30M
- Lead/follow: 21% lead, 79% follow
- Last fund: Likely actively investing — fresh fund, raised $50M in 2026
Portfolio highlights
- Eight19 — Eight19, located in Cambridge, UK, develops and manufactures plastic photovoltaics for energy harvesting, for the internet of things and for off-grid applications. Through the innovative use of industry-standard, high-volume, roll-to-roll processes and solution-based organic photoactive materials, the company has a highly cost-effective route forscaling-up its technology to supply the largest markets. Eight19 is currently producing modules on a small scale for commercial partners with applications in indoor energy harvesting for wireless sensor and controllers, signage and display, and outdoor power for portable electronics. Our plastic PV modules benefit from flexibility, thinness, light-weight and robustness.
- Slamcore — Positioning, mapping and perception | State-of-the-art visual SLAM turns sensor data into actionable, spatial understanding for your vehicles.
- Mach42 — Machine Discovery is a University of Oxford spin-out commercializing new machine learning technology. We leverage proprietary neural network technology to accelerate expensive calculations — and we do it with minimal data and 99.9% fidelity.
Verve Ventures has invested in more than 140 science and technology startups. We support visionary and resilient entrepreneurs from day one and are a reliable partner for the entire journey. We typically invest EUR 1-3m in early as well as later stage rounds of European high tech startups.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Series A, Seed, Series B
- Geography: Switzerland, Germany, France
Investor stats
- Total investments: 298
- Round size: Seed $1.4M–$11M; Series A $2.1M–$18M; Series B $3.9M–$45M
- Lead/follow: 14% lead, 86% follow
- Last fund: Likely still investing — raised $61M in 2022
Portfolio highlights
- Axelera AI — Axelera AI is a company that delivers purpose-built hardware and software platforms designed to accelerate artificial intelligence tasks, particularly in edge computing. The company's flagship product, the Metis™ AI Platform, integrates both hardware and software components to deliver high-performance, energy-efficient AI inference solutions.This platform has been recognized for its innovation, notably being named a CES® 2024 Innovation Awards Honoree.Incubated in 2019 by the emerging technologies leader Bitfury and joined by the leading nano-technology group imec in early 2020, Axelera AI launched as a new company in 2021. Headquartered in the AI Innovation Center of the High Tech Campus in Eindhoven, Axelera AI has R&D offices in Belgium, Switzerland, and Italy. Its team of experts in AI software and hardware hail from top AI firms and Fortune 500 companies.
- Aylight — Aylight develops semiconductor laser and photonics platforms designed to improve optical connectivity in AI datacenters and related infrastructure. The company focuses on frequency modulated comb laser technology that generates multiple stable wavelengths from a single InP-based laser cavity. Its architecture produces an equidistant, RF-lockedwavelength grid that aligns with dense wavelength-division multiplexing requirements and reduces control complexity and power consumption. Aylight targets use cases in AI datacenter interconnects, quantum computing hardware, precision metrology, and communication equipment. Its products aim to integrate with terabit optical links and wavelength-division multiplexing systems while remaining compatible with existing fabrication processes.
- Atana Elements — Atana is accelerating the exploration and development of flowing critical minerals and industrial gases. Atana uses a proprietary tech stack to identify and mature mineral resources quickly and effectively.
Amadeus Capital Partners, Venture Capital For Technology Companies. We Back Entreprenuers To Win. Contact Our Experienced Team Of Investors Today
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Series A, Seed, Series B
- Geography: United Kingdom, United States, Spain
Investor stats
- Total investments: 267
- Round size: Seed $800k–$9.2M; Series A $2.6M–$30M; Series B $7.2M–$56M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely still investing — raised $85M in 2023
Portfolio highlights
- Tenzo — Tenzo is a restaurant analytics and AI forecasting platform for restaurants, pubs and cafes. Tenzo makes running restaurants easy with full data visibility.
- Slamcore — Positioning, mapping and perception | State-of-the-art visual SLAM turns sensor data into actionable, spatial understanding for your vehicles.
- Respiro Diagnostics — Respiro is harnessing insights from the breath to detect lung cancer earlier, non-invasively, and without scans or radiation. Built for use in everyday care settings.
Formic Ventures is a diversified venture capital firm that makes early-stage investments in biotechnology startups focused on human longevity as well as technology startups and companies that make human lives more meaningful.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: United States, United Kingdom, Hong Kong
Investor stats
- Total investments: 47
- Round size: Seed $958k–$9M; Series A $17M–$61M; Venture - Series Unknown $2.4M–$3.1M
- Lead/follow: 2% lead, 98% follow
Portfolio highlights
- SonoThera — Explore therapeutic ultrasound for non-invasive, targeted genetic medicine delivery that improves precision and biodistribution. Learn more.
- cheMastery — Echo handles repetitive tasks with accuracy and precision, allowing your chemists to tackle high-value challenges.
- Biogenesis — Clinical research platform tailored towards industry sponsors, clinical research sites & patients
Advent Life Sciences is a venture team investing in life sciences businesses. The team consists of 11 professionals with extensive scientific, medical and operational experience, and a long-standing track record of entrepreneurial and investment success across the UK, Europe and the US. The Firm invests in a range of sectors within life sciences,principally in new drug discovery, enabling technologies, and med tech. Realizations in the last three years include Algeta, Avila, CN Creative, EUSA, Micromet. Current investments include Acutus, Biocartis, Cellnovo, f2G, NeRRe,
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 70
- Round size: Series A $5.5M–$51M; Series B $21M–$105M
- Lead/follow: 36% lead, 64% follow
- Last fund: May invest from a new fund soon — last raise in 2021
Portfolio highlights
- Cyted — Cyted focuses on providing digital diagnostic infrastructure to drive the earlier detection of disease. Our technologies use AI and novel biomarkers to improve patient outcomes.
- Glycomine — We are developing a PMM2-CDG substrate replacement therapy. GLM101 is a mannose-1 phosphate treatment.
- Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
Discover the UK's leading SEIS Fund, offering tax-efficient investments in innovative startups. Join thousands of savvy investors and raise capital for your business with SFC Capital.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Pre-Seed, Seed
- Geography: United Kingdom, United States, Canada
Investor stats
- Total investments: 488
- Round size: Seed $127k–$2M; Pre-Seed $164k–$839k
- Lead/follow: 36% lead, 64% follow
- Last fund: May invest from a new fund soon — raised $1.9M in 2019
Portfolio highlights
- Sages — Biodegradeable, non-polluting, low-impact and vibrant dyes extracted from food waste.
- Traknova — Traknova provides an AI-powered fleet management platform that helps companies track, manage, and protect vehicles and mobile assets. The platform offers real-time GPS tracking, live monitoring, and telematics data to give operators constant visibility over fleet movements and status. Users can access an intuitive dashboard with historical tripinformation, engine status, and alerts for events such as geofence breaches or unauthorized use. Traknova also supports integrated hardware, including tracking devices and online cameras, to strengthen asset security and streamline recovery when issues arise. The system is designed for fleets across industries, such as service businesses and vehicle rental operators, that need clearer scheduling, better time management, and improved operational control. By consolidating these tools into one platform, Traknova enables data-led fleet planning and day-to-day decision-making.
- GNOSIS Health — Gnosis Health is a digital healthcare platform specializing in artificial intelligence and wearable technology for chronic disease management.
We build relationships early, make decisions quickly, but engage with you for the long term. Our focus is getting B2B software companies at Pre-Seed and Seed to a successful Series A.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 168
- Round size: Seed $1M–$5M; Pre-Seed $1M–$4M; Series A $5.1M–$18M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $96M in 2024
Portfolio highlights
- RevEng — RevEng.AI is a cyber security and artificial intelligence company that helps organizations understand their cyber security supply chain. RevEng.ai identifies fundamental components of closed-source program binaries and generates real-valued vector embeddings for each component.
- sable bio — We provide comprehensive, quantified, and flexible Target Safety Intelligence to assist toxicologists, informaticians, and drug discovery scientists in delivering safe and effective new treatments.
- SimplyCook — SimplyCook offers home recipe kits with easy step-by-step guides to cook restaurant-quality food in less than 20 minutes.SimplyCook boxes contain 4 easy to follow recipes and 4 ingredient kits. Each kit is designed to provide perfect taste-containing ingredient blends devised by professional chefs.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Molten Ventures is a leading British venture capital firm backing Europe’s highest-growth private technology companies. Our expert investment team stay ahead of the curve, identifying transformative trends and next-generation companies before they break through. We combine multiple pools of capital to invest at all stages of the businesslifecycle—from seed and early stage to growth and late stage—focusing on disruptive sectors like Spacetech, Fintech, and AI. Our strategy is simple: back bold ideas, scale them with capital and expertise, and unlock high-value exits—whether through strategic acquisitions, trade buy-outs, or IPOs. Since our 2016 IPO, we’ve delivered strong realised returns, reinvesting into the next wave of innovation—creating a virtuous cycle of growth and value.
Show more...Investment focus
- Industry: Software, Information Technology, FinTech
- Stage:Series A, Series B, Series C
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 230
- Round size: Series A $3.2M–$31M; Series B $7.9M–$60M; Series C $11M–$200M
- Lead/follow: 52% lead, 48% follow
- Last fund: May invest from a new fund soon — raised $7M in 2011
Portfolio highlights
- XMOS — In 2005, a small team assembled to create a fast and flexible microcontroller that would enable designers to respond quickly to diversifying market demand. The first (XS1) and second (xcore-200) generation processors put unprecedented I/O capability (available through software for the first time) alongside significant DSP and controlprocessing – establishing XMOS as a name in the audio sector.The vision quickly shifted towards AI. Caught between two very different technical and commercial models, Graphcore was formed to focus on server-side AI, and XMOS continued the quest towards low-cost embedded intelligence (edge-AI). Most recently XMOS enabled voice to become mainstream, releasing the XVF3510 – a disruptive high-performance, low cost far-field 2-mic voice interface. This was followed up with xcore.ai – a new crossover processor for the AIoT that brings AI, DSP, control and I/O together in a single device.
- MAIA Technology — MAIA is a front-to-back asset management technology suite born out of an established asset management business with the pedigree of a decade of development and refinement.
- Mobile Travel Technologies — Mobile Travel Technologies (MTT) is the leading mobile travel technology specialist for airlines, hotels and travel intermediaries with an extensive customer base across the global travel industry.MTT’s advanced mobile travel platform powers some of the most successful and highest revenue generating mobile channels in the travel industry. As apioneer in this space having first launched mobile bookings for airlines in 2006, MTT has remained a first mover in mobile travel and has picked up many awards along the way for its successful, customer focused travel apps & mobile sites. MTT offers its clients unrivalled travel industry expertise, world-class mobile development, creative design, mobile usability expertise and a sophisticated mobile travel platform. MTT clients include Saudi Arabian Airlines (Saudia), the flag carrier for Kingdom of Saudi Arabia, LAN Airlines in Chile and TAM Airlines in Brazil (the LATAM Airlines Group), easyJet, transavia.com of the Air France KLM Group, Flybe, Jumeirah Group and Atlantis The Palm, Dubai.
Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Venture - Series Unknown
- Geography: United Kingdom, United States, Hungary
Investor stats
- Total investments: 143
- Round size: Seed $250k–$2.1M; Venture - Series Unknown $406k–$5.3M
- Lead/follow: 66% lead, 34% follow
- Last fund: May invest from a new fund soon — last raise in 2013
Portfolio highlights
- Ben — Ben is the all-in-one platform for any company to personalise benefits and reward.Our secret? Marrying a modern software (SaaS) platform with per-employee Mastercards and financial infrastructure. That’s how Ben instantly adds employee choice to your existing benefits, unlocks access to hundreds of additional options through Ben Card, all whilesaving you time and money.
- Distil.ai — Distil.ai is a software platform that helps businesses to understand their customers’ behavior and identify buying signals.
- MRC Engineering — MRC Engineering Providing a different option to the UK Rail Industry for Telecoms Design. Nationally renowned design specialists who provide extraordinary ...
We are a leading early-stage investment platform. We are at the center of a global ecosystem that attracts and fuels the technical founders and product teams building the next wave of global businesses.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 383
- Round size: Seed $1.1M–$8M; Pre-Seed $500k–$3.3M; Series A $4.9M–$25M
- Lead/follow: 5% lead, 95% follow
- Last fund: Likely actively investing — fresh fund, raised $2.9M in 2026
Portfolio highlights
- Rapidata — Fast and reliable data labeling that powers your AI. Define your label needs now and get the results in minutes.
- Devplan — Devplan is an AI-powered workspace for product development teams, transforming ideas into execution-ready plans by integrating with tools like GitHub, Linear, Jira, and company docs.
- Applied Atomics, Inc. — Powering the next 1,000 years of advanced industry with co-located nuclear power plants.
Ahren Innovation Capital is a World Changing Institution. A group of highly diverse, creative and original thinkers, at the cutting edge of their domains.
Show more...Investment focus
- Industry: Biotechnology, Artificial Intelligence, Machine Learning
- Stage:Series A, Seed, Series B
- Geography: United Kingdom, United States, Israel
Investor stats
- Total investments: 45
- Round size: Seed $2.7M–$15M; Series A $10M–$58M; Series B $15M–$150M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- KluraLabs — CodiKoat are a revolutionary company developing and producing the future of antiviral protection. CodiKoat's antiviral surface coating technology is ISO certified and is the fastest COVID-killing protection of its kind in the world, with limitless uses.
- Cassidy Bio — A biotechnology company developing AI-driven genomic foundation models
- Adrestia Therapeutics — Adrestia is developing therapeutics that work in an entirely new way – restoring the biological balance in damaged, diseased or dying cells
AlbionVC supports visionary founders and technologies with long-term capital and scale-up know-how. Founded in 1996, it was amongst the first to back leading global success stories such as Booking.com, Egress, Quantexa and Oviva. With £1bn in AUM and over 100 exits successfully realised, it funds venture breakthroughs that drive real outcomes forfounders, investors and society. AlbionVC is the technology investment arm of Albion Capital Group, which is authorised and regulated by the Financial Conduct Authority. For more information please visit: https://albion.vc/
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Series A, Seed
- Geography: United Kingdom, United States, France
Investor stats
- Total investments: 179
- Round size: Seed $2.4M–$12M; Series A $3.9M–$19M
- Lead/follow: 42% lead, 58% follow
Portfolio highlights
- geoSurge — Customers don't search. They ask.
- Oshen — Oshen is a technology enterprise that creates miniature autonomous sailboats designed for persistent, wide-area ocean tracking.
- Gravitee — Open Source API Management Platform - Gravitee
Martlet Capital is an early-stage investor based in Cambridge, providing patient capital to deep technology and life science startups with high growth potential. Investing in the future.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, United States
Investor stats
- Total investments: 55
- Round size: Seed $525k–$7.5M; Pre-Seed $193k–$1.2M; Series A $1M–$9.5M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Xampla — Xampla's natural plant polymer technology is the innovative technology powering materials to change the world with plastic-free replacements and more.
- Infinitopes — Infinitopes is a cancer research organization whose mission is to strengthen the immune system so that it can stop metastases and save lives. The company's platform creates healthcare systems and therapy designs to integrate high-efficiency vector delivery systems with optimal tumor target identification technologies in early-stage clinicaltrials, allowing patients to prevent cancer and tumors from taking their lives
- AllFocal Optics — AllFocal Optics revolutionizes display technology through groundbreaking nanophotonic solutions.
Playfair is a sector agnostic fund focused exclusively on pre-seed investing. Based in London, Playfair invests across the UK and Europe with an intentionally high conviction, low volume approach: making six investments a year out of its third $70m fund and preserving time, capital and resource to help companies post-investment. Our 78% Series Agraduation rate is ~3x industry average. Playfair has backed 100+ companies since 2013, including Thought Machine, Orca AI, Protex AI, StackOne and Nory.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Machine Learning
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, United States, Switzerland
Investor stats
- Total investments: 153
- Round size: Seed $1.2M–$7.6M; Pre-Seed $953k–$3.1M; Series A $3M–$19M
- Lead/follow: 24% lead, 76% follow
- Last fund: Likely still investing — raised $70M in 2023
Portfolio highlights
- Navifare — Navifare is an AI-powered travel price optimization and metasearch platform that focuses on flight, hotel, and car rental price comparison. The platform analyzes flight offers users already found and searches for lower fares from online travel agencies and airlines. Users can upload screenshots, paste flight details, or use a Chrome extension thatoverlays a “Find Better Fare” button on major booking sites. Navifare exposes its price discovery capabilities via a web app, a REST API, and an MCP server for integration into AI assistants. It redirects users to partner sites to complete bookings and does not handle payments directly.
- Zerolook — Zerolook provides a flight-shopping API for online travel agencies, airlines, metasearch services, and AI travel applications. Its machine-learning model predicts flight prices and itineraries using historical fare data instead of recomputing every fare combination through a global distribution system or airline system. The API returns predicteditineraries, prices, and confidence scores for exploratory search, while customers route completed bookings through their existing distribution channels. Zerolook supports REST and MCP integrations and provides booking links to external airlines and online travel agencies.
- Exclaim Robotics — Autonomous mobile robots for the AI data center.
The team behind Catapult Ventures are among the most experienced venture capital investors in the UK.Their experience spans a range of sectors from healthcare and pharmaceuticals to luxury consumer brands, manufacturing and software, as well as all stages: from start-ups and pre-revenue IP developers to company floatation and billions of poundsin revenue. Their administration team is equally experienced with each member having more than 10 years experience in a venture capital environment.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Venture - Series Unknown
- Geography: United Kingdom, United States, Israel
Investor stats
- Total investments: 105
- Round size: Seed $150k–$5.6M; Venture - Series Unknown $370k–$5M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- Path Robotics — We create manufacturing robots that autonomously scan, position, and weld your parts without the need for skilled welders or robot programmers.
- Pickle Robot — We make robots that unload trucks without retrofitting the warehouse
- Anello Photonics — Anello Photonics is a technology company developing a silicon photonic optical gyroscope to navigate, position, and motion track autonomous applications in challenging GPS-jammed and spoofed environments. The company's technology portfolio spans over 28 issued patents, and over 44 pending patents, and includes an AI-based sensor fusion engine.It serves the robotics, defense, construction, agriculture, and autonomous vehicles industries.
WE BACK HEROES using technology to solve the world's biggest problems
Show more...Investment focus
- Industry: Biotechnology, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, Germany, Canada
Investor stats
- Total investments: 184
- Round size: Seed $2M–$15M; Series A $8.5M–$37M; Series B $16M–$91M
- Lead/follow: 17% lead, 83% follow
- Last fund: Likely still investing — raised $90M in 2021
Portfolio highlights
- Gridware — Using remote telemetry and edge AI, Gridware wildfire prevention technology powers a grid that is smarter and more reliable than ever before.
- Onepot.ai — Search 2.7 billion make-on-demand analogs from onepot CORE, get a quote, and we synthesize and QC them in our US-based lab. AI-powered custom synthesis CRO.
- Adaption Labs — Adaptation creates AI systems that adjust to changing real-world circumstances.
Independent Corporate Finance Advisors & Private Equity Investors
Show more...Investment focus
- Industry: Health Care, Life Science, Biotechnology
- Stage:Seed, Series A
- Geography: United Kingdom
Investor stats
- Total investments: 4
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Neurovalens — Neurovalens delivers innovative solutions in the field of neuroscience, bioscience and neurophysiology.Neurovalens has received support from Invest NI under the European Union’s Investment for Growth and Jobs Programme. The project, recorded on the ERDF beneficiaries’ website, will be implemented over the next one year, undertaking research anddevelopment activities aimed at improving the competitiveness of the business.
Life Science Investor funding in United Kingdom at a glance
Stats across 688 deals from 802 investors.
Access all 802 investors in United Kingdom Life Science startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science Investors in United Kingdom investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 802 investors investing in United Kingdom Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!